ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Diabetic Kidney Disease Collaborative (DKD-C)

Working Together to Address the Urgent and Unmet Needs in the Diagnosis and Treatment of People with Diabetic Kidney Disease

Diabetic Kidney Disease Virtual Roundtable Series: 

ASN's DKD-C Task Force is hosting a virtual roundtable series for healthcare providers and individuals with diabetes and kidney disease.  The series includes the following three events.  Register today!

Listen to the recording:

Management of Diabetes & Kidney Disease through COVID-19

Recorded on Tuesday, Aug 18, 2020

12:00 PM - 1:30 PM ET

Details the care needs and the patient experience managing diabetes and kidney disease during the COVID-19 pandemic. Outlines frequent patient concerns, and provide strategies for maintaining health.  

Topics presented include:

·         Population Susceptibility To Diabetes

·         Diabetes and Kidney Disease during COVID-19

·         COVID-19 and DKD Management: A Personal Journey

·         Patient Access to New Therapies

·         Coordinating DKD Care: Who Takes Care Of My Diabetes, And Who Takes Care Of My Kidneys?

·         Roundtable Discussion



Goal-Directed Medical Therapies for Patients with Diabetic Kidney Disease

Tuesday, Sept 29, 2020
12:00 PM - 1:30 PM ET

Leading experts in the care of individuals with diabetic kidney disease (DKD) will describe what is the new standard of care for DKD, discuss the clinical indications for SGLT2 inhibitors, and consider payment issues associated with new therapies. The session will conclude with a roundtable discussion of key questions, including those submitted by the videoconference participants.  

Topics for presentation and discussion:

  • What is The Standard of Care for Diabetic Kidney Disease?
  • Safely and Effectively Prescribing SGLT2 Inhibitors
  • Paying for New Therapies
  • DAPA-CKD Study
  • EMPEROR-Reduced Study
  • Roundtable Discussion


New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes

Thursday, Dec 10, 2020
4:00 PM - 5:30 PM ET

Clinical experts will review the latest guidelines for both kidney disease and heart disease, and discuss the most recent trials and promising therapies. A roundtable of experts from nephrology, cardiology, and endocrinology will consider implications for diabetes, kidney and heart disease treatment in 2021.  

Topics for presentation and discussion:

·         Evolving Landscape For Diabetic Kidney Disease

·         Kidney Disease Guideline Overview

·         Cardiovascular Disease Guideline Overview

·         Roundtable Discussion

Recording | Slides | Speaker Bios | 
Why Should I Join A Clinical Trial?

Register Here

Register Here

Support of the Diabetic Kidney Disease Collaborative is provided by Bayer, Boehringer Ingelheim and Lilly, AstraZeneca, and Janssen Pharmaceuticals, Inc.DKD-C Supporters